Population
Porcine aortic smooth muscle cells
Comparison
IGF-I vs control
Design
Preclinical in vitro laboratory study
Key result
IGF-I up-regulates IGFBP-5 synthesis by transcriptionally activating the IGFBP-5 gene in aortic smooth muscle cells, with the promoter being 3.5-fold more active in treated cells.
Authors
Loading...
Hypothesis-generating in aortic smooth muscle cells; leaves open relevance to human vascular disease.
IGF-I specifically up-regulates IGFBP-5 synthesis in aortic smooth muscle cells via transcriptional activation, providing insight into vascular smooth muscle cell regulation.
Clemmons et al. (2021) studied this question. Insulin-like Growth Factor-I (IGF-I) vs. Control cells was evaluated on IGFBP-5 synthesis and mRNA levels. IGF-I up-regulates IGFBP-5 synthesis by transcriptionally activating the IGFBP-5 gene in aortic smooth muscle cells, with the promoter being 3.5-fold more active in treated cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: